MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
MONITOR-CKD5 is an observational, pharmaco-epidemiological study to evaluate the multi-level
factors and outcomes associated with the treatment of renal anaemia with biosimilar epoetin
alfa in Stage 5 CKD patients requiring haemodialysis.